UnitedHealth Group Incorporated (UNH) shares are up 4% to $122 in pre-market trading after it reported fiscal results for the first quarter.
In its quarterly report, the largest U.S. health insurer said it earned $1.46 per share, well above the $1.35 per share analysts were expecting. Revenue rose 12.8% to $35.76 billion, above views for $34.63 billion. Net earnings came in at $1.41 billion, or $1.46 a shares, compared to $1.09, or $1.10 a share from a year earlier.
For full-year 2015, UNH provided EPS guidance of $6.15 – $6.30 versus consensus of $6.21 per share. The company also issued revenue projection of $143 billion, compared to the consensus revenue estimate of $141.73 billion.
On valuation measures, UnitedHealth Group Inc. shares, which currently have an average 3-month trading volume of 3.57 million shares, trade at a trailing-12 P/E of 20.58, a forward P/E of 16.71 and a P/E to growth ratio of 1.91. The median Wall Street price target on the name is $133.00 with a high target of $149.00. Currently ticker boasts 18 ‘Buy’ endorsements, compared to 6 ’Holds’ and no ‘Sell’.
Profitability-wise, UNH has a t-12 profit and operating margin of 4.31% and 7.87%, respectively. The $111.89 billion market cap company reported $8.65 billion in cash in its most recent quarter.
UNH currently prints a one year return of about 51% and a year-to-date return of around 16.50%.
The chart below shows where the equity has traded over the last 52 weeks.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The firm was founded in 1974 and is based in Minnetonka, Minnesota.